DE60233685D1 - Verfahren zur herstellung einer zusammensetzung mis resultierende produkt - Google Patents

Verfahren zur herstellung einer zusammensetzung mis resultierende produkt

Info

Publication number
DE60233685D1
DE60233685D1 DE60233685T DE60233685T DE60233685D1 DE 60233685 D1 DE60233685 D1 DE 60233685D1 DE 60233685 T DE60233685 T DE 60233685T DE 60233685 T DE60233685 T DE 60233685T DE 60233685 D1 DE60233685 D1 DE 60233685D1
Authority
DE
Germany
Prior art keywords
phase
resulting product
mis
active
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60233685T
Other languages
English (en)
Inventor
Ferreira Amado Elizabeth Molenda
De Souza Fernando Rafael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diffucap Chemobras Quimica E F
Original Assignee
Diffucap Chemobras Quimica E F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diffucap Chemobras Quimica E F filed Critical Diffucap Chemobras Quimica E F
Application granted granted Critical
Publication of DE60233685D1 publication Critical patent/DE60233685D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE60233685T 2001-01-17 2002-01-03 Verfahren zur herstellung einer zusammensetzung mis resultierende produkt Expired - Lifetime DE60233685D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR0100334-8A BR0100334A (pt) 2001-01-17 2001-01-17 Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante
PCT/BR2002/000001 WO2002102129A2 (en) 2001-01-17 2002-01-03 Process for the preparation of programmed liberation compositions with venlafaxine and the resulting product

Publications (1)

Publication Number Publication Date
DE60233685D1 true DE60233685D1 (de) 2009-10-22

Family

ID=37734022

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60233685T Expired - Lifetime DE60233685D1 (de) 2001-01-17 2002-01-03 Verfahren zur herstellung einer zusammensetzung mis resultierende produkt

Country Status (12)

Country Link
US (1) US7563456B2 (de)
EP (1) EP1578342B1 (de)
AT (1) ATE442136T1 (de)
AU (1) AU2002224680A1 (de)
BR (1) BR0100334A (de)
CY (1) CY1109535T1 (de)
DE (1) DE60233685D1 (de)
DK (1) DK1578342T3 (de)
ES (1) ES2333302T3 (de)
MX (1) MXPA03003530A (de)
PT (1) PT1578342E (de)
WO (1) WO2002102129A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0100334A (pt) * 2001-01-17 2002-09-24 Diffucap Chemobras Quimica E F Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
AU2003226752A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Venlafaxine base
WO2003094899A1 (es) * 2002-05-09 2003-11-20 Diffucap-Chemobras Química E Farmacéutica, Ltda. Nuevo procedimiento para la preparacion de composiciones de liberacion programada conteniendo (s) -1- [n-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-l-proline, y al producto obtenido por dicho procedimiento
CA2507685A1 (en) * 2002-11-28 2004-06-10 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci
EP1502587B1 (de) 2003-07-30 2006-08-23 Pharmathen S.A. Venlafaxine Hydrochloridformulierungen mit verzögerter Freisetzung
US20090175934A1 (en) * 2006-03-08 2009-07-09 Jubilant Organosys Ltd. Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same
US20070248669A1 (en) * 2006-04-25 2007-10-25 Fang-Hsiung Hsiao Oral sustained release formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
EP0113373B1 (de) * 1982-07-09 1991-08-28 Key Pharmaceuticals, Inc. Dosierungsart zur dauerhaften verabreichung von chinidin
US6001848A (en) * 1996-03-25 1999-12-14 The Regents Of The University Of California Bromocriptine for the treatment of alcoholics diagnosed with the D2 dopamine receptor DRD2 A1 allele
DE60035579T2 (de) * 1999-05-20 2008-04-17 Elan Corp. Plc Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
BR0100334A (pt) * 2001-01-17 2002-09-24 Diffucap Chemobras Quimica E F Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante

Also Published As

Publication number Publication date
US20040131677A1 (en) 2004-07-08
ES2333302T3 (es) 2010-02-19
WO2002102129A2 (en) 2002-12-27
DK1578342T3 (da) 2010-01-18
PT1578342E (pt) 2009-12-15
US7563456B2 (en) 2009-07-21
AU2002224680A1 (en) 2003-01-02
MXPA03003530A (es) 2005-01-25
WO2002102129A3 (en) 2006-12-07
AU2002224680A8 (en) 2007-02-01
EP1578342B1 (de) 2009-09-09
CY1109535T1 (el) 2014-08-13
EP1578342A2 (de) 2005-09-28
BR0100334A (pt) 2002-09-24
ATE442136T1 (de) 2009-09-15

Similar Documents

Publication Publication Date Title
CY1109535T1 (el) Μεθοδος για παρασκευη συνθεσης προγραμματισμενης απελευθερωσης με βενλαφαξινη και το προκυπτον προϊον
WO2006125620A3 (en) Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
WO2007054976A3 (en) Lipid based controlled release pharmaceutical composition
NO20053799L (no) Blanding innbefattende blanding av aktive bestanddeler og en fremgangsmate ved fremstilling derav
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
UA86413C2 (ru) Сахарное покрытие и твердая дозированая форма, которая его содержит
WO2006055511A3 (en) Stable tablet formulation of tetrahydrobiopterin
BRPI0401779A (pt) Combinações adesivas ricas em corpos sólidos para lacas de cobertura estáveis ao risco
WO2006117211A3 (en) Urea derivatives methods for their manufacture and uses thereof
FI914354A0 (fi) Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
DE60102850T2 (de) Verfahren zur Herstellung von wässrigen Beschichtungszusammensetzungen
HUP0000140A2 (hu) Tárolással szemben stabil felszabadulásprofillal rendelkező retard tramadolkészítmények és eljárás ezek előállítására
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
WO2003057150A3 (en) A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
WO2007087026A3 (en) Solid-state form of amg 706 and pharmaceutical compositions thereof
WO2006069154A3 (en) Vitamin d receptor modulators
ATE308537T1 (de) Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
NO20052197D0 (no) Fremgangsmate for fremstilling av pyrazol
ATE346510T1 (de) Gelierzucker und verfahren zu dessen herstellung
RU2016106384A (ru) Противотуберкулезная стабильная фармацевтическая композиция в форме таблетки с покрытием, содержащей гранулированный изониазид и гранулированный рифапентин, и способ ее приготовления
WO2008029351A3 (en) A modified release formulation comprising amoxicillin and clavulanate
DE60108105D1 (de) Verfahren zur Herstellung von 5-substituierten Isobenzofuranen
ATE380018T1 (de) Verfahren zur herstellung von wirkstoffhaltigen pellets
ATE370155T1 (de) Verfahren zur herstellung von funktionalisierten beta-(1,3)-glucanderivaten
DE10344970A1 (de) Verfahren zur Identifizierung präbiotisch wirksamer Substanzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition